Literature DB >> 10434874

Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.

B Laliotou1, A D Dick.   

Abstract

BACKGROUND/AIM: Nasal administration of retinal antigens induces systemic tolerance which results in suppression of experimental autoimmune uveoretinitis (EAU) when subsequently exposed to antigen. The aim was to establish if tolerance induction alters retinal infiltrating leucocyte phenotype and cytokine profile in tolerised animals when there is significantly reduced tissue destruction despite immunisation with retinal antigen.
METHODS: Female Lewis rats were tolerised by intranasal administration with retinal extract (RE) before immunisation with RE to induce EAU. Control animals were administered phosphate buffered saline (PBS) intranasally. Post immunisation, daily clinical responses were recorded and at the height of disease, retinas were removed and either infiltrating leucocytes isolated for flow cytometric phenotype assessment and intracellular cytokine production, or chorioretina processed for immunohistochemistry. Fellow eyes were assessed for cytokine mRNA by semiquantitative RT-PCR.
RESULTS: Flow cytometric analysis showed that before clinical onset of EAU there is no evidence of macrophage infiltration and no significant difference in circulating T cell populations within the retina. By day 14 a reduced retinal infiltrate in tolerised animals was observed and in particular a reduction in numbers of "activated" (with respect to CD4 and MHC class II expression) macrophages. Immunohistochemistry confirmed these findings and additionally minimal rod outer segment destruction was observed histologically. Cytokine analysis revealed that both IL-10 mRNA and intracellular IL-10 production was increased in tolerised eyes 7 days post immunisation. Although by day 14 post immunisation, IL-10 production was equivalent in both groups, a reduced percentage of IFN-gamma + macrophages and IFN-gamma + CD4+ T cells with increased percentage of IL-4+ CD4+ T cells were observed in tolerised animals.
CONCLUSIONS: Leucocytic infiltrate is not only reduced in number but its distinct phenotype compared with controls implies a reduced activation status of infiltrating monocyts to accompany increased IL-10 and reduced IFN-gamma production in tolerised animals. This modulation may in turn contribute towards protection against target organ destruction in EAU.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434874      PMCID: PMC1723017          DOI: 10.1136/bjo.83.4.478

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  33 in total

1.  Suppression of murine collagen-induced arthritis by nasal administration of collagen.

Authors:  L K Myers; J M Seyer; J M Stuart; A H Kang
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity.

Authors:  B Metzler; D C Wraith
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

3.  Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial.

Authors:  R B Nussenblatt; I Gery; H L Weiner; F L Ferris; J Shiloach; N Remaley; C Perry; R R Caspi; D A Hafler; C S Foster; S M Whitcup
Journal:  Am J Ophthalmol       Date:  1997-05       Impact factor: 5.258

4.  Presumed ocular histoplasmosis syndrome in The Netherlands.

Authors:  G J Roper; H J Kaplan
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

5.  Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.

Authors:  C Prussin; D D Metcalfe
Journal:  J Immunol Methods       Date:  1995-12-15       Impact factor: 2.303

Review 6.  Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens.

Authors:  A D Dick; Y F Cheng; J Liversidge; J V Forrester
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

7.  Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.

Authors:  A D Dick; P G McMenamin; H Körner; B J Scallon; J Ghrayeb; J V Forrester; J D Sedgwick
Journal:  Eur J Immunol       Date:  1996-05       Impact factor: 5.532

8.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.

Authors:  Y Chen; J Inobe; V K Kuchroo; J L Baron; C A Janeway; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.

Authors:  A D Dick; Y F Cheng; J Liversidge; J V Forrester
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Authors:  J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  5 in total

1.  Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy.

Authors:  A D Dick; V Sharma; J Liversidge
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

2.  Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis.

Authors:  Cathryn Broderick; Robert M Hoek; John V Forrester; Janet Liversidge; Jonathon D Sedgwick; Andrew D Dick
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction.

Authors:  H R Jiang; N Taylor; L Duncan; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

4.  In vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.

Authors:  Xiangting Chen; Jelena M Kezic; John V Forrester; Gabrielle L Goldberg; Ian P Wicks; Claude C Bernard; Paul G McMenamin
Journal:  J Neuroinflammation       Date:  2015-01-27       Impact factor: 8.322

5.  Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis.

Authors:  Jacqueline A Quandt; Pierre Becquart; Emily Kamma; John Hallenbeck
Journal:  Front Mol Neurosci       Date:  2019-08-27       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.